Production Core
生产核心
基本信息
- 批准号:9359634
- 负责人:
- 金额:$ 163.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdoptionAllelesAreaBiotechnologyClinicalClinical ResearchCommunicationCommunitiesComputer softwareConfusionConsumptionDataDatabasesDepositionDevelopmentDiseaseElectronic Health RecordEnvironmentFundingGenesGeneticGenetic screening methodGenomeGenomic medicineGenomicsGoalsHealthHealth SurveysHealth systemHealthcareHumanHuman GeneticsHuman Genome ProjectIndividualKnowledgeLaboratoriesLinkMedical GeneticsMethodsModelingMolecular MedicineOnline Mendelian Inheritance In ManParticipantPathogenicityPatient CarePatientsProcessProductionPublic DomainsRecruitment ActivityRegistriesResearch InfrastructureResearch PersonnelResolutionResourcesSiteStandardizationStructureSystemTest ResultTestingTimeTrainingUnited States National Institutes of HealthUpdateVariantWorkclinical careclinically actionabledata exchangedata modelingdata sharingdesignexperiencefeedinggene discoverygenetic variantgenomic datagenomic variationhealth dataimprovedinformatics infrastructureknowledge basenovelopen sourceoutreachpatient registryphenotypic datastatisticstooluser-friendlyworking group
项目摘要
PROJECT SUMMARY
Although knowledge in the field of human genetics has greatly increased since the time of
the Human Genome Project, we still do not fully understand all of the ways in which genomic
variation contributes to human health and disease. This proposal represents one of three
linked U41 applications to continue support for the Clinical Genome Resource (ClinGen;
www.clinicalgenome.org). The main goals of the ClinGen project are to support the
deposition of genomic and health data into the public domain by all stakeholders, including
patients, clinicians, laboratories, and researchers, develop methods and an informatics
infrastructure to answer critical questions of the data (curation), and create a genomic
knowledge base that makes this information available to the community for improved patient
care. We have structured this proposal into five overarching aims to meet ClinGen's goals: 1)
data sharing, 2) standardized approaches to interpretation of genes and variants, 3) software
and informatics infrastructure to support and enhance interpretation, 4) community-driven
efforts for curation and interpretation, and 5) outreach to maximize the impact of the ClinGen
resource. To make high-quality genomic variant data available to the public, we will build
upon the standards, experience and infrastructure we have developed during our first funding
period. We will capitalize on our collaborative relationships with clinical laboratories to
capture the clinical-grade interpretations of millions of genetic sequencing tests generated
through the course of routine patient clinical care. All genomic variants and their
interpretations will continue to be submitted to and made accessible through our partnership
with the ClinVar database within NIH's National Center for Biotechnology Information (NCBI).
We will also help to augment the genomic data with phenotype data collected through
GenomeConnect, ClinGen's patient registry for individuals who have had genetic testing.
ClinGen will use this shared genomic and health information to answer critical questions
regarding relevance to human health and disease around clinical validity for gene/disease
associations, variant pathogenicity and clinical actionability. Clinical Domain Working Groups
(CDWG) and Expert Panels (EP) will enable disease experts to curate sets of genes and
variants following approaches developed as part of the ClinGen project. Finally, we will make
the ClinGen knowledge base widely available by
developing “clinician-friendly” user interfaces
and supporting automatic EHR updates through the newly developed ClinGen EHR App
to
improve the quality of patient care through genomic medicine.
项目摘要
尽管人类遗传学领域的知识自1960年以来已经大大增加,
尽管人类基因组计划,我们仍然没有完全理解基因组的所有方式,
变异有助于人类健康和疾病。该提案代表了三个方面之一
链接U41应用程序,以继续支持临床基因组资源(ClinGen;
www.clinicalgenome.org)。ClinGen项目的主要目标是支持
所有利益攸关方将基因组和健康数据存入公共领域,包括
患者,临床医生,实验室和研究人员,开发方法和信息学
基础设施,以回答数据的关键问题(策展),并创建一个基因组
知识库,使这些信息可用于社区,以改善患者
在乎我们将该提案分为五个总体目标,以实现ClinGen的目标:1)
数据共享,2)解释基因和变异的标准化方法,3)软件
和信息学基础设施,以支持和加强解释,4)社区驱动
策展和解释的努力,以及5)外展,以最大限度地发挥ClinGen的影响
resource.为了向公众提供高质量的基因组变异数据,我们将建立
我们在第一次融资期间开发的标准,经验和基础设施
期我们将利用与临床实验室的合作关系,
捕获数百万个基因测序测试产生的临床级解释
通过常规的患者临床护理过程。所有基因组变异及其
将继续通过我们的伙伴关系提交并提供解释
与NIH国家生物技术信息中心(NCBI)的ClinVar数据库进行比较。
我们还将通过以下途径收集表型数据,
GenomeConnect,ClinGen的患者登记处,用于进行基因检测的个人。
ClinGen将使用这些共享的基因组和健康信息来回答关键问题
关于基因/疾病临床有效性与人类健康和疾病的相关性
关联性、变异致病性和临床可操作性。临床领域工作组
(CDWG)和专家小组(EP)将使疾病专家能够策划基因组,
作为ClinGen项目的一部分开发的方法的变体。最后,我们将
ClinGen知识库可通过
开发“临床医生友好”的用户界面
并通过新开发的ClinGen EHR App支持自动EHR更新
到
通过基因组医学提高患者护理质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HEIDI L REHM其他文献
HEIDI L REHM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HEIDI L REHM', 18)}}的其他基金
Tracking Ethical Provenance for Sharing Genomic and Health Related Data
追踪共享基因组和健康相关数据的道德来源
- 批准号:
10791228 - 财政年份:2021
- 资助金额:
$ 163.6万 - 项目类别:
The Global Alliance for Genomics and Health: Setting the Standards for Genomics and Health-Related Data Sharing
全球基因组学与健康联盟:制定基因组学和健康相关数据共享标准
- 批准号:
10089618 - 财政年份:2021
- 资助金额:
$ 163.6万 - 项目类别:
The Global Alliance for Genomics and Health: Setting the Standards for Genomics and Health-Related Data Sharing
全球基因组学与健康联盟:制定基因组学和健康相关数据共享标准
- 批准号:
10343724 - 财政年份:2021
- 资助金额:
$ 163.6万 - 项目类别:
Empirical Validation of GA4GH's Data Use Ontology with NIH Datasets' Data Use Limitations
GA4GH 数据使用本体与 NIH 数据集数据使用限制的实证验证
- 批准号:
10367297 - 财政年份:2021
- 资助金额:
$ 163.6万 - 项目类别:
The Global Alliance for Genomics and Health: Setting the Standards for Genomics and Health-Related Data Sharing
全球基因组学与健康联盟:制定基因组学和健康相关数据共享标准
- 批准号:
10554330 - 财政年份:2021
- 资助金额:
$ 163.6万 - 项目类别:
Partners Healthcare Training Program in Precision and Genomic Medicine
精准与基因组医学合作伙伴医疗保健培训计划
- 批准号:
10394807 - 财政年份:2019
- 资助金额:
$ 163.6万 - 项目类别:
Partners Healthcare Training Program in Precision and Genomic Medicine
精准与基因组医学合作伙伴医疗保健培训计划
- 批准号:
10671450 - 财政年份:2019
- 资助金额:
$ 163.6万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 163.6万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 163.6万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 163.6万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 163.6万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 163.6万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 163.6万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 163.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 163.6万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 163.6万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 163.6万 - 项目类别: